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Effect of dietary protein on the renin-angiotensin system in subtotafly
nephrectomized rats. Dietary protein restriction improves the course of
renal disease in the remnant kidney model. Dietary protein restriction
can also reduce plasma renin activity in several circumstances. We
examined the interaction between dietary protein and the renin-angio-
tensin system in subtotally nephrectomized rats (1-2/3 nephrectomy).
No difference was seen in tissue renin activity in rats ingesting a high
(30%) versus a low (6%) protein diet. To determine the pathophysiolog-
ical role of angiotensin II in subtotally nephrectomized rats, we
examined the acute renal response to an intrarenal infusion of the
angiotensin II antagonist Sar' G1y8-angiotensin 11(10 g/kgImin). Only
those subtotally nephrectomized animals ingesting a high protein diet
exhibited a consistent improvement in glomerular permselectivity, as
manifested by a 24% fall in the fractional clearance of albumin (basal
16.19 3.65 x iO vs. Sar1 Gly-AII 12.26 3.21 x iO-; P < 0.02)
and a 19% fall in the fractional clearance of IgG (basal 3.75 0.67 x
l0 vs. Sar' Gly8-AII 3.03 0.48 x i0; P < 0.02). No consistent
change occurred in glomerular permselectivity in the rats on the low
protein diet or rats infused with vehicle only. No change in mean
arterial pressure or whole-kidney hemodynamics were seen with angi-
otensin II blockade. Decrements in SNGFR and glomerular capillary
pressure occurred with angiotensin blockade in the animals ingesting
the high protein diet, suggesting hemodynamic factors as a mechanism
for the improvement in permselective defects. In conclusion, dietary
protein intake determines the glomerular response to angiotensin II
blockade, implicating local angiotensin H as an injurious factor with
high protein feeding in subtotally nephrectomized rats.
Dietary protein restriction improves the course of most
experimental renal diseases and appears to have similar effects
in clinical renal diseases [1—4]. In the experimental setting
restriction of dietary protein is associated with a reduction in
glomerular pressure and a blunting of compensatory growth,
both adaptive responses of the diseased kidney [3—5]. Plasma
renin activity varies with the level of dietary protein being
higher on a high protein diet when measured in normal animals,
normal human subjects, and in humans with a variety of
glomerular diseases [6—11]. Angiotensin II has marked effects
on renal hemodynamics and may affect renal growth [12, 131.
Due to the preferential constricting effects of this hormone on
the efferent arteriole, increases in glomerular pressure occur
which may have injurious consequences to the glomerulus [14,
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15]. Inhibition of angiotensin II formation by the use of con-
verting enzyme inhibitors has been associated with decreased
renal injury in both the experimental and clinical setting [16,
17]. Therefore, the pathophysiological link between dietary
protein and renal injury may reside in the stimulation of the
renin-angiotensin system by dietary protein.
The purpose of these studies was to examine more closely the
interaction between dietary protein and the renin-angiotensin
system following subtotal nephrectomy. The effects of dietary
protein on tissue renin activity (TRA) in subtotally nephrecto-
mized animals was first examined. Since measurement of TRA
may not reflect the biological effects of angiotensin II, we
examined the acute response to the intrarenal infusion of an
angiotensin II antagonist in subtotally nephrectomized animals
on a low and high protein diet.
Methods
Our investigation consisted of three studies, designated I, II,
III, all of which involved the use of the remnant model of
chronic renal failure in the rat. This model was made by
removal of the right kidney and segmental infarction of 2/3 of
the left kidney under methohexital anesthesia (5 mg/100 g body
wt, i.p.). After the nephrectomy the rats were maintained on
standard rat chow (Ralston Purina Co., St. Louis, Missouri,
USA, 24% protein) for two weeks, at which time serum
creatinine was measured on a Beckman Creatinine Analyzer II
(Beckman Instruments, Inc., Fullerton, California, USA) from
a tail vein blood sample. The animals were stratified according
to their serum creatinine to insure similar levels of reduced
renal function and assigned to either a 6% protein diet (Tekiad
Diet #TD83437, Tekiad, Madison, Wisconsin, USA) or a 30%
protein diet (Teklad Diet #TD85445) for an additional two
weeks, at which time the studies described below were per-
formed. Stratification was performed by first ranking from
lowest to highest the two-week serum creatinine (Cr) values and
then assigning every other animal alternatively to the two diets,
thus matching mean Cr values. The two diets were isocaloric
and had identical electrolyte contents containing (in g/kg): 0.76
Na, 2.68 K, and 0.74 Cl. They differed in protein contents and
in the sucrose added to the 6% diet to ensure that both diets
were isocaloric. The protein source for the diets was casein.
Study I: Effect of dietary protein on tissue renin activity
Male Sprague-Dawley rats underwent 1-2/3 nephrectomy (N
= 12). The animals were maintained on standard rat chow for
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two weeks, at which time they were assigned to either the 6% or
30% protein diet. After two weeks on these diets the remnant
kidney was removed and divided into weighed aliquots for
determination of tissue renin activity, protein concentration,
and nephron number. For determination of nephron number I
ml of colloidal carbon was injected via an intra-arterial line
directed into the left ventricle. The kidney was removed and an
aliquot placed in 2 ml of concentrated HCI for four hours, and
then in distilled water overnight. The acid digested kidney
tissue was gently agitated and suspended in a total volume of 10
ml and with the kidney being constantly stirred, 50 il aliquots
were removed and glomeruli counted. For determination of
tissue renin activity, the kidney aliquots were kept at —20°C in
1 ml of distilled water until their renin content was measured.
The kidney was homogenized, spun at 5000 rpm, and the
supernate removed. The pellet was resuspended in 1 ml of
distilled water, recentrifuged, and the two supernatants com-
bined. The supernatants were then frozen and thawed four
times. Tissue renin activity was determined on the aliquot of
supernatant after dilution to 1: 1000. Fifty pi of the sample was
incubated for one hour with 25 d of plasma obtained from
nephrectomized male rats, 90 l of phosphate buffer, 25 sl 4%
EDTA, 5 d dimercaprol, and 5 p1 8 hydroxyquinoline [18, 19].
The protein concentration of the supernatant was measured by
the Coomassie brilliant blue dye method of Bradford [20].
Tissue renin activity per mg of protein was determined by
dividing tissue renin activity by the protein concentration, both
being measured in the supernatant of homogenized kidney.
Tissue renin activity per nephron was calculated by dividing the
tissue renin activity of the supernatant by the number of
nephrons calculated to be present in the fragment used for
measurement of TRA.
Study 11: Effect of angiotensin II blockade on whole kidney
hemodynamics and glomerular permselectivity
Male Sprague-Dawley rats underwent 1-2/3 nephrectomy.
After two weeks on standard rat chow the animals were
stratified according to their serum creatinines and assigned to
either a 6% protein diet (N = 7) or a 30% protein diet (N = 9).
After two weeks on these diets, renal clearance studies were
performed examining the response to the angiotensin II antag-
onist Sar1 G1y8-angiotensin II (Sar-Gly; Sigma Chemicals, St.
Louis, Missouri, USA). Rats were anesthetized with mactin
(100 mg/kg body wt administered by intraperitoneal injection;
BYK Gulden, Konstanz, FRG) and placed on a temperature-
regulated table. A PE-50 polyethylene catheter was inserted
into the left femoral artery for blood sampling and blood
pressure monitoring by a pressure transducer (model P23 Db,
Statham Instruments, Oxnard, California, USA) connected to a
duograph recorder (model 1CT-2H Gilson Medical Electronics,
Middleton, Wisconsin, USA). After femoral artery catheteriza-
tion a blood sample was immediately taken for measurement of
hematocrit and total plasma protein. Hematocrit was deter-
mined by a micro-capillary hematocrit reader (International
Equipment Co., Neeham Heights, Massachusetts, USA). Total
plasma protein was determined by refractometry. The trachea
was catheterized with PE-240 tubing and the left external
jugular vein was catheterized with PE-50 for infusion. The left
ureter was catheterized with PE-lO and urine was collected
under mineral oil in pre-weighed vials. To determine GFR a
solution of normal saline containing (methoxy 3H) inulin (10
pCi/mi) was infused at a rate of 1.2 mI/hr after a priming dose of
0.5 ml over five minutes. A 23 gauge needle connected to a
tuberculin syringe by a length of PE-50 tubing was inserted into
the left renal vein to obtain renal venous samples. Filtration
fraction was calculated from the extraction of inulin across the
kidney. After allowing 30 minutes for equilibration, two twenty-
minute clearance collections were performed during which
normal saline was infused at a rate of 0.5 mI/hr into the left renal
artery via a 33 gauge needle (Hamilton Company, Reno, Ne-
vada, USA). Position of the left renal artery needle was
confirmed by injection of a dilute solution (1: 100) of lissamine
green. Following these two baseline periods the left renal artery
infusate was changed from normal saline to the angiotensin II
antagonist Sar' G1y8-angiotensin II mixed with normal saline
and infused at a rate of 0.5 mI/hr. The amount of Sar' Gly8-
angiotensin II infused was 10 pg/kg/min. After a 15 minute
equilibration period, two twenty-minute clearance collections
were performed. Following these collections an intravenous
infusion of angiotensin 11(13 ng/kglmin) (Sigma Chemicals, St.
Louis, Missouri, USA) was started, during which the intrarenal
G1y8-angiotensin II infusion was continued. Fifteen min-
utes after the start of angiotensin II infusion two further
twenty-minute clearance collections were done.
To replace surgical losses and to maintain constancy of initial
hematocrit, all animals were infused with isooncotic rat plasma
as follows: 1% of body weight was administered over 20
minutes and an infusion rate of 0.5 mI/hr was maintained
throughout the study [21].
Radioactivity in the urine and plasma were determined by
liquid scintillation counting. Urinary and plasma levels for both
IgG and albumin from samples collected during the clearance
periods were measured by rate nephelometry using an immu-
nochemistry analyzer (Beckman Instruments, Inc.). Goat-de-
rived anti-rat IgG and anti-rat albumin (Cappel Laboratories,
Malvern, Pennsylvania, USA) were used to generate the anti-
gen-antibody reaction used in their respective nephelometric
reactions. Fractional clearances of albumin and IgG were
determined by dividing the clearance of the protein by the
clearance of the filtration marker inulin. Serum and urine
sodium and potassium were measured by flame photometry.
Study III: Effect of angiotensin II blockade on sin gle-nephron
hemodynamics and glomerular permselectivity
Twelve male Sprague-Dawley rats underwent 1-2/3 nephrec-
tomy. After two weeks on a standard rat chow, the animals
were stratified according to their serum creatinines and as-
signed to either a 6% (N = 6) or a 30% (N 6) protein diet. At
the end of two weeks on these diets whole-kidney hemodynam.
ics, single-nephron hemodynamics, and urinary protein excre-
tions were determined. The animals were prepared for the
clearance studies as described in Study II. To determine GFR
and SNGFR, normal saline containing (methoxy-3H) inulin (100
isCi/ml) was infused at a rate of 1.2 mI/hr after a priming dose of
0.5 ml over five minutes. The remnant kidney was prepared for
micropuncture studies. As described in Study III, two twenty-
minute clearance periods during which normal saline was
infused into the left renal artery at a rate of 0.5 mI/hr were
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performed followed by an intrarenal infusion of Sar' G1y8-
angiotensin II at a rate of 10 /Lg/kglmin for two twenty-minute
clearance periods. The third series of clearance studies during
which angiotensin II was infused were omitted from Study III.
Besides measurement of whole-kidney GFR and filtration frac-
tion a minimum of three collections of tubular fluid were
performed for determination of SNGFR. Hydraulic pressure
measurements were made in cortical tubules and efferent arte-
rioles by the servo null micropipette technique. Glomerular
capillary pressure was measured by the stop flow methodology.
Values of proximal tubular, efferent arteriolar, and stop flow
pressures were the means of at least three determinations. The
details of the calculations employed are described below. The
urine and blood collections for measurements of IgG and
albumin are as described in Study II. Urinary protein excretion
during the clearance periods was measured by the Coomassie
brilliant blue dye method of Bradford [201.
Six additional rats who had undergone 1-2/3 nephrectomy,
two weeks on a standard diet followed by two weeks on the 30%
diet were used as a time control. They were prepared for
micropuncture studies as described above. However, during
the second set of clearance studies, the angiotensin II antago-
nist, Sar' G1y8-angiotensin II, was not infused. Instead, a left
renal artery infusion of normal saline was continued for all four
clearance periods.
Calculations
Glomerular capillary pressure
Pg = ITA + SFP
where SFP is stop-flow pressure.
Afferent artenolar osmotic pressure, ITA, is calculated from
the Landis-Pappenheimer equation
IrA = 2.1C + 0.16C2 + 0.009 C3
where C is protein concentration.
Mean glomerular transcapiliary hydraulic pressure gradient
= Pg —
where T is proximal tubule hydraulic pressure.
Single nephron glomerular filtration rate
SNGFR =
tubular fluid counts/mm
SNGFR
QA= FF
where FF is filtration fraction.
Efferent arteriolar total plasma protein concentration
CA
CE =
1 — FF
The mathematical model described by Deen, Robertson and
Brenner was used to calculate the glomerular ultrafiltration
coefficient, K1 [22]. This model determines the rate of change of
6% Protein
(N= 13)
30% Protein
(N= 15)
Serum K mEqiliter 3.7 0.1 3.3 0.2
Serum Na ,nEq/liter 140 2 139 1
Urine K jjEq/24 hr 645 94 486 64
Urine Na isEq/24 hr 726 218 548 88
Data are presented as means 5EM. No significant differences were
present.
protein concentration along an idealized glomerular capillary
and requires the following input, P, QA, and CA, for the
calculation of K1.
Statistics
All data are presented as mean standard error of the mean.
To determine statistical significance between basal and Sar'
G1y8-angiotensin II periods the paired Student's t-test or
Wilcoxon Signed Rank Test was used based on whether the
data was normally distributed or not. For comparisons between
three parameters one-way ANOVA was used to determine
statistical significance and intergroup comparisons were made
using Duncan's test. Differences were considered statistically
significant for P < 0.05.
Results
Study I: Effect of dietary protein on tissue renin activity
(1) The initial body weights were not different between the 6%
and 30% animals (272 2 vs. 273 5 g; P = NS). However, the
final body weights tended to be less in the 6% compared to the
30% group (265 7 vs. 295 13 g; P = NS). Food intake was
measured at the end of the 6% and 30% dietary periods and was
not different between the two groups (6%: 12 1 vs. 30%: 16
(2) 4 g/24 hr; P = NS). Serum and urine potassium and sodium was
measured in all the animals in Study I and II and did not differ
significantly (Table 1). The nephron number was similar in the
6% compared to the 30% group (11,439 543 vs. 12,978 881;(3) P = NS), confirming similar degrees of nephron reduction.
Serum creatinines were similar between the 6% and 30% groups
at two weeks (1.03 0.10 vs. 1.00 0.06 mgldl; P NS) and
four weeks (0.88 0.07 vs. 0.92 0.12 mg/dl; P = NS). Tissue
renin activity was not different in the 6% and 30% animals when
(4) expressed as either TRA/mg protein (5.23 1.74 vs. 4.45 1.22
pg Al/hr/mg protein; P = NS) or TRA/nephron number (30.18
7.32 vs. 35.49 7.48 g AI/hr/nephron x iO; P = NS; Fig.
(5) Study II: Effect of angiotensin II blockade on whole-kidney
hernodynamics and glomerular permselectivity
As shown in Table 2, both the 6% and 30% animals began
with similar body weights; however, the final weights of the
30% group were higher than the 6% group. Kidney weight was
greater in the 30% protein fed group (wet kidney weight: 6%:(6) 1.10 0.05 vs. 30%: 1.97 0.11 g; P < 0.001; dry kidney
weight: 6%: 0.21 0.02 vs. 30%: 0.32 0.02g; P <0.001). The
serum creatinine two weeks after partial ablation, at the time of
dietary assignment, was similar by design between the two
groups as was the final serum creatinine and hematocrit. Total
Table 1. Serum and urine electrolytes, Study I and II
plasma counts/ni
Initial glomerular plasma flow rate 1).
0a
ccI-
Table 2. General parameters, Study II
6% Protein 30% Protein(N=7) (N=9)
Initial body wt g 274 6 271 8
Final body wt g 266 13 312 21
Serum creatinine mg/dl
2 wk 0.84 0.08 0.94 0.06
4 wk 0.94 0.12 0.81 0.07
Hematocrit % 43 1 41 1
Serum total protein gm/dl 5.1 0.2a 6.2 0.2
Data are presented as means SEM, 2 wk is the time of dietary
assignment.
a p < 0.05 (6% vs. 30% Protein group)
serum protein was higher in the 30% protein fed animals.
Increased urinary protein excretion was seen in the 30% com-
pared to the 6% protein fed group (77 12 vs. 26 8 mg/24 hr).
There was no significant change in mean arterial pressure
between the basal period, the Sar-Gly infusion, and the Sar-Gly
infusion combined with angiotensin II in either the 6% or 30%
protein fed groups (Fig. 2). Therefore, even though the Sar-Gly
was infused intrarenally a systemic angiotensin II blockade
occurred as indicated by the stability of arterial pressure despite
systemic infusion of a pressor dose of angiotensin II. No change
in glomerular filtration rate was seen during the three periods in
either the 6% (basal 0.65 0.04; Sar-Gly 0.65 0.07; Sar-Gly
+ angiotensin II 0.65 0.09 mllmin; P NS) or 30% groups
(basal 0.59 0.08; Sar-Gly 0.58 0.08; Sar-Gly + angiotensin
110.68 0.11 mllmin; P NS; Fig. 3). No significant changes
occurred in renal plasma flow throughout the study in the 6%
protein fed group (basal 2.76 0.34; Sar-Gly 2.82 0.39;
Sar-Gly + angiotensin 112.81 0.44 mI/mm; P = NS)nor in the
30% protein fed group (basal 2.74 0.57 mi/mm; Sar-Gly 2.57
0.62; Sar-Gly + angiotensin II 2.36 0.57; P = NS), again
demonstrating adequate angiotensin II blockade.
A significant improvement in glomerular permselectivity dur-
ing Sar-Gly infusion was seen in the 30% protein fed animals as
demonstrated by a 24% fall in the fractional clearance of
albumin (basal 16.19 3.65 vs. Sar-Gly 12.26 3.21 X 10; P
<0.02; Fig. 4) and a 19% fall in the fractional clearance of IgG
(basal 3.75 0.67 vs. Sar-Gly 3.03 0.48 x 1O; P < 0.02;
Fig. 4). No significant change in the fractional clearance of
albumin occurred in the 6% protein group during Sar-Gly
infusion (9.74 1.97 vs. Sar-Gly 8.96 1.91 x l0; P = NS;
Fig. 4). A decrease in the fractional clearance of IgG did occur
in the 6% animals during Sar-Gly infusion (basal 3.57 0.55 vs.
0
6% Protein 30% Protein
Fig. 2. Effect of angiotensin II blockade on mean arterial pressure.
MAP was measured 4 weeks after 1-2/3 nephrectomy and 2 weeks after
assignment to either a 6% protein or 30% protein diet. The basal values
are the mean of two measurements made during an intrarenal infusion
of normal saline (D); the Sar-Gly values () are the mean of two
measurements made during the intrarenal infusion of the angiotensin H
antagonist Sar' G1y8.angiotensin 11(10 ig1kg/min), and the Sar-Gly +
angiotensin H values (0) are the mean of two measurements made
during the intrarenal infusion of Sar' Gly8 angiotensin 11(10 sg/kgImin)
and the systemic infusion of angiotensin 11(13 ng/kg/min). Values are
mean + SEM. N = 7 for the 6% protein group and N = 9 for the 30%
protein group. NS is nonsignificant.
Sar-Gly 3.22 0.49 x iOn; P < 0.05; Fig. 4). However, the fall
in the fractional clearance of IgG was only 10% in the 6%
protein fed animals compared to a 19% fall in the 30% protein
fed animals.
Study III: Effect of acute angiotensin II blockade on single-
nephron hemodynamics and glomerular permselectivity
As seen in the other studies, there was no difference in the
initial weights between the animals. However, the final weights
in the 30% protein fed group were higher than the 6% group
(Table 3). No differences between the three groups were seen
for serum creatinine at either two weeks or four weeks, final
hematocrit, or final serum total protein (Table 3).
Whole kidney and single nephron hemodynamics are dis-
played in Table 4. Basal values for MAP, GFR, RPF, SNGFR,
QA, and KF were not significantly different between the 6% and
the two 30% groups. The 30% protein fed rats did have
significantly higher P0, P, and 11A compared to the 6%
protein fed group. As seen in Study II, Sar-Gly infusion resulted
A
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Fig. 1. Effect of dietary protein on tissue renin
activity (TRA): Study 1. TRA was measured 2
weeks after assignment to either a 6% or 30%
protein diet. TRA is expressed in the left graph
as TRAImg of protein and in the right hand graph
as TRA/nephron. Values are mean SEM. No
significant differences were seen.6% Protein 30% Protein 6% Protein 30% Protein
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Fig. 3. Effect of angiotensin I! blockade on glomerular filtration rate.
GFR was measured 4 weeks after the animals have undergone 1-1/3
nephrectomy and 2 weeks following assignment to either a 6% protein
or a 30% protein diet. See legend for Figure 2 for details of the graph.
Symbols are: (D) basal; () SAR-GLY, (0) SAR-GLY ÷ Ang II.
in no change in mean arterial pressure, GFR, or renal plasma
flow compared to basal infusion in all three groups. Single
nephron GFR (SNGFR) decreased significantly during Sar-Gly
infusion in the 30% group and tended to decline in the 6%
protein group, but no change in SNGFR was seen in the time
control. In the 30% protein fed group the fall in SNGFR was
attended by a fall in glomerular pressure, whereas in the 6%
group no significant change in glomerular pressure occurred.
Except for a small decrement in 11Ano significant hemodynamic
changes were observed in the 30% time control infused with
vehicle alone.
Similar changes in glomerular permselectivity occurred in
these animals as were observed in Study II. Total urinary
protein excretion decreased significantly in the 30% protein
group during Sar-Gly infusion (16 3 vs. 10 1 g/min; P <
0.04) whereas no change occurred during Sar-Gly infusion in
the 6% protein group (7 2 vs. 6 1 p.glmin; P = NS). As
shown in Figure 5, a 25% fall in the fractional clearances of
albumin (basal 3.82 0.85 vs. Sar-Gly 2.88 0.82 x iOn; P <
0.02) and a 21% fall in the fractional clearance of IgG (basal 2.13
0.55 vs. Sar-Gly 1.68 0.54 x iOn; P < 0.02) occurred in
the 30% protein fed group, whereas no significant changes were
seen in the fractional clearances of albumin (basal 1.63 0.53
vs. Sar-Gly 1.22 0.32 x ion; P = NS) or IgG (basal 1.46
0.43 vs. Sar-Gly 1.12 0.29 x io; P = NS) in the 6% protein
fed group (Fig. 5). In the time control, no significant change in
total urinary protein excretion (basal 22 5 vs. Sar-Gly 22 6
p.glmin; P = NS), or in the fractional clearances of albumin
(basal 2.03 0.58 vs. Sar-Gly 1.94 0.41 x io; P = NS) or
IgG (basal 1.52 0.31 vs. Sar-Gly 1.37 0.29 x iOn; P = NS)
were seen (Fig. 6), thus confirming that the improvement in
permselectivity seen in the 30% protein-fed animals was a
specific effect of Sar-Gly and not simply due to the duration of
the experiment.
Discussion
No significant difference in tissue renin activity was seen
between the rats ingesting the high compared to the low protein
diet. Tissue renin activity, however, may be a poor marker of
the biological effects of angiotensin II. Other components of the
renin-angiotensin system can affect the kinetics of angiotensin
II formation. For instance, the renin substrate angiotensinogen
can be cleaved by other proteolytic enzymes other than renin,
such as tonin and cathepsin G, thus bypassing the renin step
[23, 24]. Furthermore, a large storage pool of both active and
inactive renin is present in the kidney [25]. In some studies as
much as 50% of total renal renin was present in the inactive
form [26]. Therefore, the procedures commonly used to mea-
sure tissue renin content do not necessarily reflect the true
amount of active renin present in the kidney. Also, heteroge-
neity of renin content per nephron is present in the normal
kidney with deeper nephrons having higher renin contents than
superficial nephrons [19]. If similar heterogeneity of renin exists
following subtotal nephrectomy then measurement of total
renin content would not be reflective of the individual nephron
effects of angiotensin II. Even if tissue renin content was an
accurate marker of angiotensin II formation, once angiotensin
II was formed its biological effects could be modified by
changes in angiotensin II receptor number and affinity, post-
receptor events, and the presence of other hurnoral factors such
as prostaglandins. Finally discrepancies between PRA, TRA,
renin mRNA (reflecting the local renin-angiotensin system), and
responses to angiotensin II blockade or inhibition of angiotensin
II formation have been demonstrated in the chronic phase of
two-kidney, one-clip hypertension, following converting en-
zyme inhibition in adrenalectomized rats, and in rats on a low
sodium diet plus furosemide [27—29]. A more definitive test of
angiotensin II as the responsible agent in any condition would
be blockade with a specific angiotensin II antagonist.
Therefore to examine the interaction between dietary protein
and angiotensin II following subtotal nephrectomy we exam-
ined the acute response to an intrarenal infusion of the angio-
tensin II antagonist Sari G1y8-angiotensin II in animals ingesting
a high or a low protein diet. This antagonist was chosen because
of its relative absence of agonist effects [30]. The effect of
angiotensin blockade depended on prior dietary protein intake.
Animals ingesting the higher protein diet exhibited a consistent
improvement in glomerular permselectivity supporting a patho-
physiologic role for angiotensin II in the generation of the more
severe proteinuria seen on the high protein diet. This effect was
manifested by a fall in total protein excretion, and the fractional
clearances of albumin and IgG in the animals ingesting the high
protein diet after antagonist infusion. A small but significant fall
in the fractional clearance of IgG with angiotensin II antagonist
infusion did occur in the 6% protein fed group in Study II but
not Study III, and therefore may represent a dependence of size
selectivity on angiotensin II in this group. The stable protein
excretions seen in the time control animals provide further
evidence for a specific effect for angiotensin II blockade and
militate against changes in proteinuria being due to other
experimental conditions. Although the etiology and the effects
of dietary protein on proteinuria following subtotal nephrec-
tomy undoubtedly involve multiple factors, the beneficial ef-
r-NS
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Table 3. General parameters, Study III
30% Protein
6% Protein 30% Protein time control(N=6) (N=6) (N=6)
Initial body wt g 232 8 237 10 253 5
Final body wt g 282 8 324 6 321 31
Serum creatinine mg/dl
2 wk 0.87 0.05 0.90 0.12 0.89 0.11
4 wk 0.77 0.06 0.67 0.07 NM
Hematocrit % 44 1 44 1 44 2
Serum total protein gIdi 6.2 0.1 6.4 0.1 6.6 0.2
fects of dietary protein restriction are due at least in part to a
decrease in the intrarenal effects of angiotensin II.
Dietary protein restriction reduces renal injury in virtually all
experimental renal diseases [1]. As well, growing clinical evi-
dence supports a beneficial role of low protein diets in slowing
the progression of human renal disease [2, 311. Many factors
may be responsible for this beneficial effect. A low protein diet
lowers glomerular capillary pressure, blunts renal growth,
reduces acid load, and affects immune function [3—5, 32].
Changes in protein intake are often accompanied by decreased
phosphorus intake and alterations in the quantity and quality of
lipid intake. Several of these factors may contribute to the
beneficial effects of dietary protein restriction. Angiotensin II is
yet another candidate for mediating many of the adverse effects
of high dietary protein in the setting of renal disease. Angioten-
sin II is a potent renal vasoconstrictor with effects on both the
afferent and efferent arterioles. The predominant effects of
angiotensin II are on the efferent arteriole resulting in increased
glomerular capillary pressure [12, 14, 15]. Both exogenous
infusion of angiotensin II and elevations of endogenous levels
by maneuvers such as renal vein constriction evoke glomerular
permselective defects [33, 34]. The resultant increase in mesan-
gial uptake of macromolecules may induce mesangial growth
abnormalities and may be a contributing factor in glomerular
sclerosis [35]. Renal growth at both the tubular and glomerular
level is induced by high protein intake [36]. Enlargement of
glomeruli may predispose to injury due to the increased wall
tension that would be generated at a given pressure to an
enlarged glomerular capillary wall (37]. Angiotensin II may play
a role in modulating renal growth as evidenced by the potenti-
ation of epidermal growth factor-induced renal tubular growth
and by the effect of angiotensin II to increase thymidine
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Fig. 4. Effect of angiotensin ii blockade on
glomerular permselectivity: Study II.
Measurements were made 4 weeks after the
animals have undergone 1-2/3 nephrectomy
and 2 weeks following assignment to either a
6% or a 30% protein diet. Symbols are: (D)
basal; () SAR-GLY. A. The values for the
fractional clearances of albumin. B. Values for
the fractional clearances of IgG. Values are
mean SEM. N = 7 for the 6% protein group
and N = 9 for the 30% protein group. *fJ <
0.05; < 0.02.
incorporation by cultured mesangial cells [13, 38]. Finally,
angiotensin II increases ammoniagenesis by proximal tubular
cells [39]. High levels of ammonia, by activating the alternative
complement cascade may promote tubular and interstitial injury
[40].
Consistent with the idea that angiotensin II may be an
important mediator of renal injury are the findings that chronic
blockade of angiotensin II formation by converting enzyme
inhibitors reduces renal injury in both subtotally nephrecto-
mized and diabetic rats [16, 41]. Clinical studies, although not
definitive, also suggest a beneficial effect of converting enzyme
inhibitors on the course of renal disease [17, 42]. Therefore, the
two most successful strategies for progressive renal disease,
dietary protein restriction and converting enzyme inhibition
have in common a decrease in the renal effect of angiotensin II.
Glomerular permselective defects, in particular size selective
defects, regularly mark renal injury. In general, their presence
is associated with more severe histological patterns and a
greater tendency of renal disease to progress to end-stage [43].
The lower urinary protein excretion in the 6% protein fed group
signifies a beneficial effect of this diet in reducing renal injury.
Renal histological changes, although not examined in the cur-
rent study, have been demonstrated to accompany the reduced
proteinuria seen in animals on low protein diets in previous
studies [3—5]. The more severe glomerular permselective de-
fects seen in the animals on a high protein diet, and their
improvement after administration of the angiotensin II antago-
nist, implicates angiotensin II as an injurious agent. To explore
the mechanisms by which angiotensin II exerts its injurious
effects, we examined the renal hemodynamic response to the
infusion of an angiotensin II antagonist. Basal GFR and
SNGFR did not differ between the two dietary groups a finding
consistent with previous studies where dietary protein manip-
ulation was instituted after renal injury becomes established [4].
Basal glomerular capillary pressure was however, higher in the
30% protein group. Mean arterial pressure and whole-kidney
hemodynamics did not change with angiotensin II antagonism.
The lack of an acute change in MAP with angiotensin II
antagonist therapy is consistent with the findings of other
investigators [44, 45]. A significant fall in glomerular pressure,
measured by stop-flow, and SNGFR occurred in the animals on
the high protein diet after Sar' Gly8-angiotensin II infusion,
while glomerular pressure remained stable and a non-significant
decrease in SNGFR occurred in the animals on the low protein
diet. Glomerular pressure and SNGFR did not significantly
change in the high protein fed, time control animals. These
results suggest the improvement in permselectivity in the high
C
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2 flhr'I
6% Protein 30% Protein 6% Protein 30% Protein
Data are presented as means SEM. NM, not measured. 2 wk is the
time of dietary assignment.
a p < 0.05 (6% vs. 30% Protein groups)
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Table 4. Effect of angiotensin II blockade on whole-kidney and single-nephron hemodynamics (Study HI)
N
MAP
mm Hg
GFR RPF
FF
SNGFR QA KF
ni/si
mm Hg
TA PGC P
ni/mmmi/mm mm Hg
6% Protein 6
Basal 133 9 0.72 0.07 3.46 0.57 0.21 0.03 61 5 322 74 0.046 0.006 18 1 57 2 44 2
SAR-GLY 125 7 0.71 0.07 3.14 0.39 0.22 0.02 50 5 236 36 0.037 0.005 15 1 54 2 40 I
P valuea NS NS NS NS NS NS NS <0.05 NS NS
30% Protein 6
Basal 120 3 0.79 0.16 3.98 0.65 0.20 0.01 70 4 371 45 0.042 0.005 20 1 66 2 53 2
SAR-GLY 117 2 0.74 0.14 3.4! 0.46 0.21 0.01 58 3 284 23 0.042 0.004 18 1 59 2 45 2
P valuea NS NS NS NS <0.05 = 0.06 NS <0.05 <0.05 <0.05
P valu&' NS NS MS NS NS NS NS <0.05 <0.05 <0.05
30% Protein 6
time control
Basal 135 11 0.90 0.15 7.57 1.78 0.14 0.01 63 5 514 67 0.037 0.004 23 1 71 2 55 2
NS 139 8 0.96 0.11 6.68 1.18 0.15 0.01 65 4 420 38 0.032 0.002 21 1 70 1 56 2
P valuea MS NS NS NS NS NS NS <0.05 NS NS
P valuet NS NS NS <0.05 NS NS NS <0.05 <0.05 <0.05
Data are presented as means SEM.
a p value basal vs. SAR-GLY
b p values Basal 30% vs. Basal 6%
to hemodynamic changes. Support for this conclusion is pro-
vided by the observation that endogenous elevations of angio-
tensin II by renal vein constriction raised glomerular pressure
and worsened glomerular permselectivity [34]. As well, acute
manipulation of glomerular pressure by infusion of acetyicho-
line or angiotensin II in rats with Heymann nephritis directly
affected glomerular permselectivity [461. This interpretation is
rendered more uncertain, however, by the fall in SNGFR seen
in the high protein animals after angiotensin II blockade while
whole-kidney GFR remained stable. This combination of find-
ings could be consistent with either a shift of filtration to deeper
nephrons or a differential modulation of superficial nephron
GFR by tubuloglomerular feedback. Angiotensin II antagonists,
high protein diets, and renal ablation have all been demon-
strated to blunt tubuloglomerular feedback [47—49]. Therefore,
SNGFR and glomerular pressure may not be different in undis-
turbed superficial nephrons between control and angiotensin II
blockade. Thus, the exact mechanism underlying changes in
superficial nephron GFR in this setting is likely to be complex.
Nonetheless, while the exact mechanism is at present uncer-
tain, angiotensin II does specifically contribute to the permse-
lective defect seen with the higher protein diet.
A hemodynamic mechanism for angiotensin 11-induced permse-
lective defects following renal ablation was demonstrated by
Pelayo, Quan and Shanley [44]. Using direct measurements of
glomerular pressure in Munich-Wistar rats fed a standard 22%
Fig. 5. Effect of dietary protein on glomerular
* permselectivity: Study III. These
measurements were made in the animals that
underwent micropuncture study for
determination of both whole kidney and single
nephron hemodynamics 4 weeks after 1-2/3
nephrectomy and 2 weeks after assignment to
either a 6% protein or 30% protein diet.
Symbols are: (0) basal; () SAR-GLY. The
format is similar to Figure 4. Values are mean
SEM. N = 6 for all groups. < 0.02. NS
is nonsignificant.
0
Albumin lgG
Fig. 6. Time control studies. The measurements were made 4 weeks
after the animals had undergone 1-2/3 nephrectomy and 2 weeks after
assignment to a 30% protein diet. Basal values (0) are the mean of two
measurements performed during the intrarenal infusion of normal saline
and correspond to the basal measurements in Figures 4 and 5. Time
control () values are the mean of two measurements made during the
continuation of normal saline infusion. Values are mean SEM. N = 6.
NS is nonsignificant.
protein diet, these investigators demonstrated a fall in glomerular
pressure in association with a reduction in proteinuria following
angiotensin II inhibition. The effect of dietary protein on this
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protein-fed animals with angiotensin II blockade may be related
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response was not examined. Scholey and Meyer observed no
change in glomerular pressure in rats with 5/6 nephrectomy after
the acute infusion of an angiotensin II antagonist [45]. However,
18 hours of therapy with a converting enzyme inhibitor reduced
glomerular pressure. Neither effects of dietary protein or permse-
lective changes were examined in this study. That data does,
however, raise the possibility of a nonhemodynamic mechanism
for angiotensin lI-induced permselective defects perhaps due to a
direct effect of angiotensin II on barrier function. Support also
exists for the role of the renin-angiotensin system in mediating
some of the deleterious effects of high protein intake in the setting
of renal disease. Converting enzyme inhibition improved glomer-
ular permselectivity in rats with passive Heymann nephritis, a
model of nephrosis, and following uninephrectomy only when the
rats were fed a high protein diet with no change in permselectivity
being seen in converting enzyme inhibitor rats ingesting a low
protein diet [50, 51].
In conclusion, a high protein diet did not alter tissue renin
activity in rats which had undergone subtotal nephrectomy.
Intrarenal infusion of an angiotensin II antagonist in subtotally
nephrectomized rats consistently improved glomerular permse-
lectivity in rats ingesting a high protein diet in contrast to the
minimal change in glomerular permselectivity in rats on a low
protein diet. The improvement in permselectivity in the rats on
the high protein diet may be related to a reduction in glomerular
pressure or to a non-hemodynamic action of angiotensin II.
Therefore, part of the proteinuric effects of a high protein diet
may be due to activation of the renal renin-angiotensin system.
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